Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?

Folic acid, referred to as vitamin B9, is a water-soluble substance, which participates in the synthesis of nucleic acids, amino acids, and proteins. Similarly to B12 and B6, vitamin B9 is involved in the metabolism of homocysteine, which is associated with the <i>MTHFR</i> gene. The hum...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/64ca08f0a16b45ce8188ee2ac4888cd6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:64ca08f0a16b45ce8188ee2ac4888cd6
record_format dspace
spelling oai:doaj.org-article:64ca08f0a16b45ce8188ee2ac4888cd62021-11-25T18:36:16ZDoes Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?10.3390/nu131140362072-6643https://doaj.org/article/64ca08f0a16b45ce8188ee2ac4888cd62021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4036https://doaj.org/toc/2072-6643Folic acid, referred to as vitamin B9, is a water-soluble substance, which participates in the synthesis of nucleic acids, amino acids, and proteins. Similarly to B12 and B6, vitamin B9 is involved in the metabolism of homocysteine, which is associated with the <i>MTHFR</i> gene. The human body is not able to synthesize folic acid; thus, it must be supplemented with diet. The most common consequence of folic acid deficiency is anemia; however, some studies have also demonstrated the correlation between low bone mineral density, hyperhomocysteinemia, and folic acid deficiency. Patients with inflammatory bowel disease (IBD) frequently suffer from malabsorption and avoid certain products, such as fresh fruits and vegetables, which constitute the main sources of vitamin B9. Additionally, the use of sulfasalazine by patients may result in folic acid deficiency. Therefore, IBD patients present a higher risk of folic acid deficiency and require particular supervision with regard to anemia and osteoporosis prevention, which are common consequences of IBD.Alicja Ewa RatajczakAleksandra Szymczak-TomczakAnna Maria RychterAgnieszka ZawadaAgnieszka DobrowolskaIwona Krela-KaźmierczakMDPI AGarticlefolic acidhomocysteineinflammatory bowel diseasemicrobiotaNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4036, p 4036 (2021)
institution DOAJ
collection DOAJ
language EN
topic folic acid
homocysteine
inflammatory bowel disease
microbiota
Nutrition. Foods and food supply
TX341-641
spellingShingle folic acid
homocysteine
inflammatory bowel disease
microbiota
Nutrition. Foods and food supply
TX341-641
Alicja Ewa Ratajczak
Aleksandra Szymczak-Tomczak
Anna Maria Rychter
Agnieszka Zawada
Agnieszka Dobrowolska
Iwona Krela-Kaźmierczak
Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
description Folic acid, referred to as vitamin B9, is a water-soluble substance, which participates in the synthesis of nucleic acids, amino acids, and proteins. Similarly to B12 and B6, vitamin B9 is involved in the metabolism of homocysteine, which is associated with the <i>MTHFR</i> gene. The human body is not able to synthesize folic acid; thus, it must be supplemented with diet. The most common consequence of folic acid deficiency is anemia; however, some studies have also demonstrated the correlation between low bone mineral density, hyperhomocysteinemia, and folic acid deficiency. Patients with inflammatory bowel disease (IBD) frequently suffer from malabsorption and avoid certain products, such as fresh fruits and vegetables, which constitute the main sources of vitamin B9. Additionally, the use of sulfasalazine by patients may result in folic acid deficiency. Therefore, IBD patients present a higher risk of folic acid deficiency and require particular supervision with regard to anemia and osteoporosis prevention, which are common consequences of IBD.
format article
author Alicja Ewa Ratajczak
Aleksandra Szymczak-Tomczak
Anna Maria Rychter
Agnieszka Zawada
Agnieszka Dobrowolska
Iwona Krela-Kaźmierczak
author_facet Alicja Ewa Ratajczak
Aleksandra Szymczak-Tomczak
Anna Maria Rychter
Agnieszka Zawada
Agnieszka Dobrowolska
Iwona Krela-Kaźmierczak
author_sort Alicja Ewa Ratajczak
title Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
title_short Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
title_full Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
title_fullStr Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
title_full_unstemmed Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
title_sort does folic acid protect patients with inflammatory bowel disease from complications?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/64ca08f0a16b45ce8188ee2ac4888cd6
work_keys_str_mv AT alicjaewaratajczak doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
AT aleksandraszymczaktomczak doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
AT annamariarychter doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
AT agnieszkazawada doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
AT agnieszkadobrowolska doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
AT iwonakrelakazmierczak doesfolicacidprotectpatientswithinflammatoryboweldiseasefromcomplications
_version_ 1718410895040708608